This map shows the geographic impact of R Bettini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Bettini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Bettini more than expected).
This network shows the impact of papers produced by R Bettini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Bettini. The network helps show where R Bettini may publish in the future.
Co-authorship network of co-authors of R Bettini
This figure shows the co-authorship network connecting the top 25 collaborators of R Bettini.
A scholar is included among the top collaborators of R Bettini based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with R Bettini. R Bettini is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Bettini, R, et al.. (2005). [Prognostic value of serum beta2-microglobulin in multiple myeloma].. PubMed. 96(2). 81–6.5 indexed citations
3.
Delise, Pietro, Paolo Zeppilli, Luigi D’Andrea, et al.. (2005). Cardiological guidelines for competitive sports eligibility.. PubMed. 6(8). 661–702.15 indexed citations
4.
Delise, Pietro, Paolo Zeppilli, Luigi D’Andrea, et al.. (2005). [Cardiological protocols on evaluation of fitness for competitive sports].. PubMed. 6(8). 502–46.4 indexed citations
5.
Bettini, R, et al.. (2003). [Effectiveness of mesoglycan in the prevention of cerebral ischemia].. PubMed. 154(1). 13–6.1 indexed citations
6.
Bettini, R, et al.. (2003). [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy].. PubMed. 94(11). 494–500.
7.
Bettini, R & Marco Gorini. (2002). [Reaction times during citicoline treatment].. PubMed. 153(4). 247–50.3 indexed citations
8.
Bettini, R, et al.. (1998). Multiple myeloma index: verification of a new prognostic approach with evaluation of treatment response.. PubMed. 83(8). 708–13.2 indexed citations
9.
Bettini, R, et al.. (1997). Verification and comparison of two different predictive equations in Hodgkin's disease.. PubMed. 82(3). 324–7.2 indexed citations
10.
Bettini, R, et al.. (1994). [Clinical and instrumental evaluation of the effect of tiapride in senile involutional syndrome].. PubMed. 144(3). 231–6.1 indexed citations
Bettini, R, et al.. (1984). Primary gastrointestinal non-Hodgkin's lymphomas: analysis of 20 consecutive cases.. PubMed. 68(5). 638–45.3 indexed citations
19.
Furlanello, F, Giuseppe Inama, M Ferrari, et al.. (1981). [Another type of interaction between blood levels of digitalis and anti-arrhythmic drugs: digoxin and amiodarone. Experience with long-term therapy].. PubMed. 11(11). 1725–8.8 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.